Addendum. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021;44(Suppl. 1):S125–S150
Author:
Publisher
American Diabetes Association
Subject
Advanced and Specialised Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference2 articles.
1. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
2. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Trends in lipid profiles and control of LDL-C among adults with diabetes in the United States: An analysis of NHANES 2007–2018;Nutrition, Metabolism and Cardiovascular Diseases;2023-07
2. Treatment of Hypertension;JAMA;2022-11-08
3. Adherence to Clinical Guidelines on STATIN Prescribing Among Diabetic Patients Aged 40–75 Years Old in a Primary Care Setting: A Cross-Sectional Study;Patient Preference and Adherence;2022-08
4. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis;Current Atherosclerosis Reports;2022-04-30
5. Diabetes Medications and Cardiovascular Disease Prevention;Korean Journal of Family Practice;2022-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3